Literature DB >> 10592397

Does mountaineering increase the incidence of cutaneous melanoma? A hypothesis based on cancer registry data.

M Moehrle1, C Garbe.   

Abstract

Exposure to ultraviolet radiation is considered a major risk factor for the development of cutaneous melanoma. In white populations in Australia or the USA, the melanoma incidence increases with the vicinity of residence to the equator. In Europe decreasing incidence rates towards southern countries may be due to the darker pigmentation of the Mediterranean population. The comparison of age-standardized incidence rates (world standard population) in Europe shows that Swiss cancer registries and the Austrian Tyrol registry have much higher incidence rates for cutaneous melanoma than other Central European cancer registries. The excess of Swiss/Austrian incidence rates is even more pronounced when head localization is analysed separately. Due to the altitude-related increase in UV radiation two possible explanations for the Swiss/Austrian excess rates may be considered: firstly, as a result of the altitude of residence, higher UV exposure is generally present in these countries; secondly, mountaineering activities may additionally increase UV exposure.

Entities:  

Mesh:

Year:  1999        PMID: 10592397     DOI: 10.1159/000018274

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

1.  Effects of Radon and UV Exposure on Skin Cancer Mortality in Switzerland.

Authors:  Danielle Vienneau; Kees de Hoogh; Dimitri Hauri; Ana M Vicedo-Cabrera; Christian Schindler; Anke Huss; Martin Röösli
Journal:  Environ Health Perspect       Date:  2017-06-16       Impact factor: 9.031

2.  Is Multidirectional UV Exposure Responsible for Increasing Melanoma Prevalence with Altitude? A Hypothesis Based on Calculations with a 3D-Human Exposure Model.

Authors:  Michael Schrempf; Daniela Haluza; Stana Simic; Stefan Riechelmann; Kathrin Graw; Gunther Seckmeyer
Journal:  Int J Environ Res Public Health       Date:  2016-09-28       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.